GlassScriptPhysician profile
Robert Grady Bruce
NPI 1356323448
$9,496.29
in general payments reported to CMS, 2019-2025
38 companies · $1,840 in 2025
The $1,840 reported for 2025 was more than what 78% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,284 · 2020: $281 · 2021: $612 · 2022: $953 · 2023: $1,220 · 2024: $2,306 · 2025: $1,840.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,152 · Travel and Lodging: $1,214.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,152.17 |
| Travel and Lodging | $1,213.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,799.46 | 2019-2024 | Ams 800 Artificial Urinary Sphincter |
| Abbvie INC. | $1,537.30 | 2019-2025 | Botox |
| Bluewind Medical | $1,444.93 | 2024-2025 | Revi |
| Medtronic, INC. | $1,269.41 | 2022-2025 | Interstim |
| Coloplast Corp | $489.58 | 2019-2025 | Altis |
| Allergan, INC. | $409.92 | 2019-2022 | |
| Janssen Biotech, INC. | $345.12 | 2019-2025 | Erleada, Balversa |
| Sumitomo Pharma America, INC. | $304.35 | 2023-2025 | Orgovyx, Gemtesa |
| Pfizer INC. | $272.94 | 2021-2025 | |
| Astellas Pharma US INC | $252.40 | 2019-2024 | Xtandi |
| Endo Pharmaceuticals INC. | $221.37 | 2020-2024 | Xiaflex, Aveed |
| Valencia Technologies Corporation | $127.88 | 2025 | Ecoin Device Kit |
| Olympus America INC. | $123.03 | 2025 | Itind System |
| Merck Sharp & Dohme LLC | $85.61 | 2024-2025 | Lynparza |
| Procept Biorobotics Corporation | $67.62 | 2022 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Bruce listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.